[The immunogenic properties of a recombinant vaccinia virus with an incorporated DNA copy of the 26S RNA of the Venezuelan equine encephalomyelitis virus].
A recombinant strain of vaccinia virus (VR26) containing a DNA-copy of the subgenomic 26S RNA of Venezuelan equine encephalomyelitis virus (VEE) inserted into the coding region of thymidine kinase (TK) gene was produced. This subgenomic RNA contained the genes for all structural proteins of the VEE virus, the strain Trinidad donkey (TRD). VR26 effectively expressed VEE virus glycoproteins on the membranes of the infected cells. Blood sera of VR26-immunized animals were found to contain VEE virus-specific antibodies. VR26-immunized mice and rabbits showed a high level of resistance to subcutaneous inoculation with the pathogenic TRD strain of VEE virus. VR26 also provided a high level of protection in animals against aerogenic infection. The absence of virus-neutralizing antibodies in most VR26-immunized animals resistant to inoculation with high doses of VEE suggests the dominant role of the cell component in the immune response. The immune response induced by the recombinant VR26 strain was stable as demonstrated by the resistance of the animals to a challenge with VEE virus 7 months after immunization. The experimental results suggest that this recombinant strain may be considered as a candidate for vaccine preparation.
Sviatchenko
V A
VA
Agapov
E V
EV
Urmanov
I Kh
IKh
Serpinskiĭ
O I
OI
Frolov
I V
IV
Kolykhalov
A A
AA
Ryzhikov
A B
AB
Netesov
S V
SV
D000818:Animals; D018076:DNA, Complementary / Q000235:genetics*; D004279:DNA, Viral / Q000235:genetics*; D004666:Encephalitis Virus, Venezuelan Equine / Q000235:genetics*; D004685:Encephalomyelitis, Venezuelan Equine / Q000276:immunology / Q000517:prevention & control; D015967:Gene Expression Regulation, Viral / Q000235:genetics / Q000276:immunology*; D007106:Immune Sera / Q000276:immunology; D007114:Immunization / Q000379:methods; D051379:Mice; D012333:RNA, Messenger / Q000235:genetics*; D012335:RNA, Ribosomal / Q000235:genetics*; D012367:RNA, Viral / Q000235:genetics*; D011817:Rabbits; D011995:Recombination, Genetic / Q000235:genetics / Q000276:immunology*; D013997:Time Factors; D014615:Vaccinia / Q000276:immunology / Q000517:prevention & control; D014616:Vaccinia virus / Q000235:genetics / Q000276:immunology*
D018076:DNA, Complementary; D004279:DNA, Viral; D007106:Immune Sera; D012333:RNA, Messenger; D012335:RNA, Ribosomal; D012367:RNA, Viral; C065096:RNA, ribosomal, 26S
Immunogennye svoĭstva rekombinantnogo virusa ospovaktsiny so vstroennoĭ DNK-kopieĭ 26S RNK virusa venesuél'skogo éntsefalomielita loshadeĭ.